New England Biolabs and Color partner to provide COVID-19 testing to biotech workers essential to global pandemic response 

February 2, 2021

Today, biotech manufacturer and supplier New England Biolabs (NEB) and Color, a leading health technology company committed to advancing public health, announced their partnership providing weekly COVID-19 testing to NEB’s US-based employees. This partnership enables NEB employees to continue their essential role in manufacturing critical materials necessary for the development of COVID-19 diagnostic tests... Read More

January 4, 2021

Color, a health technology company committed to advancing public health, today announced a $167 million Series D financing round. This brings Color to $278 million in total financing, with a valuation of $1.5 billion. Color will use the... Read More

November 18, 2020

Each year the National Society of Genetic Counselors (NSGC) holds its annual conference to discuss the most pressing issues in genetic counseling, share best practices and connect genetic counselors from across the country. As with many... Read More

October 30, 2020

Today, California Governor Gavin Newsom announced Burlingame-based health technology company Color will provide software infrastructure and test collection kits in support of the collaboration between PerkinElmer Health Sciences, Inc. and... Read More

Awareness to Action: Navigating breast cancer care during the COVID-19 pandemic

October 8, 2020

During the COVID-19 pandemic, Breast Cancer Awareness Month looks a little different. For many people, routine cancer screenings have been postponed or canceled, due to concerns about the risks associated with attending in-person appointments. As always, Color observes this... Read More

19 organizations from the healthcare community unite to form COVID-19 testing industry consortium

October 1, 2020

Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating the COVID-19 Testing Industry Consortium, 19 organizations from the healthcare industry have joined forces with a goal to... Read More

With New EUA, Color’s COVID-19 self-collection kit enables public health and large private labs to increase access to testing

September 16, 2020

Color, a leading health technology company committed to advancing public health, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration that enables CLIA-certified laboratories designated by Color to use its self-swab COVID-19 collection kit for... Read More

Color and researchers from Massachusetts General Hospital and the Broad Institute discover key finding to determine risk of genomic diseases

August 19, 2020

Today, the journal Nature Communications published new research, led by scientists from Color, Massachusetts General Hospital and the Broad Institute of MIT and Harvard, that sheds light on the risk of developing three diseases: coronary artery disease, breast cancer and... Read More

Modeling SARS-CoV-2 outbreaks in workplaces, universities, and other congregate settings

August 6, 2020

The SARS-CoV-2 pandemic has upended the way we work, teach, and socialize. As the pandemic continues, institutions are solving for how to bring people back on-site safely. One of the most important aspects of returning on-site is ensuring that adequate steps are taken to protect... Read More

USC Student Health begins campus-wide COVID-19 testing with Color

July 30, 2020

University of Southern California Student Health announces that it will expand COVID-19 testing as part of its overall testing strategy to help keep students, faculty and staff safe on its campuses.  Beginning in August, the university will begin ramping up to a minimum of 500... Read More

Color receives emergency use authorization for unmonitored COVID-19 testing technology

July 27, 2020

Today, Color, a leading health technology company based in the Bay Area, announced it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration to offer COVID-19 testing without clinical monitoring. The Color test now supports unmonitored... Read More

Color News from JPM 2020

January 16, 2020

Color made a number of exciting announcements at the JP Morgan Healthcare Conference 2020 this week, including a new funding announcement, a new partnership with Sanford Health, completion of the largest clinical genomics program with Northshore Health, awards from Fierce... Read More

New Color Analysis: Patients At Risk for Diabetes Miss Crucial Screenings In Clinic

January 14, 2020

Our analysis found of those at risk for Type 2 Diabetes, 13% had not been screened for the condition in clinic, despite having visited in the last 3 years. Of that group, 86% had an ADA score of 5 or higher and 14% were pre-diabetic. Traditional diabetes screenings in clinic are... Read More

NorthShore and Color complete delivery of clinical genomics in routine care to 10,000 patients in largest U.S. program to date

January 13, 2020

A year after Color and NorthShore University HealthSystem (NorthShore) announced their partnership to integrate clinical genomics into routine primary care, the two organizations have completed the largest U.S. genomics program to date. The partnership will expand in 2020 to 30... Read More

Color and Sanford Health to scale leading genomics program, Imagenetics

January 10, 2020

Color and Sanford Health, the nation’s largest rural not-for-profit health care system, today announced together they will strengthen and scale Sanford’s leading genomics program, Imagenetics. Sanford Health and Color will build on the success of Imagenetics and provide... Read More

Color partners with Teamsters to increase access to healthcare

December 3, 2019

Color and the Teamsters Health and Welfare Fund of Philadelphia and Vicinity today announced a partnership that unlocks clinical genetics and data-driven health for nearly 14,000 members, spouses and adult dependents. This new initiative breaks down traditional barriers to... Read More

Latest Color Publications, Research, and News

November 6, 2019

Fall 2019 In this quarter’s recap of Color’s latest news, we’re sharing details about our recent grant from the National Institutes of Health, a partnership with Verily, a new population health program at Ochsner, a new employer partner in Alaska as well as an exciting... Read More

Color Makes Polygenic Scores Available to Participants Through New Study

October 17, 2019

Today, we are excited to announce our new Genetic Score Study, a research effort that makes genome-wide polygenic scores available to Color participants for the first time. These scores are a new kind of genetic analysis that integrate information from millions of changes in DNA... Read More

Color and Verily Partner to Return Actionable Genetics to Project Baseline Health Study Participants

October 10, 2019

Today we are announcing a new partnership with Verily to return actionable genetic information to all Project Baseline Health Study participants. The partnership demonstrates a commitment by Verily and Color to further research while also recognizing an ethical responsibility... Read More